Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers

Gut

Volumn 40, Issue 5, 1997, Pages 654-659

  Ilyas, M ^a,b,d   Tomlinson, I P M ^b,c   Hanby, A ^e   Talbot, I C ^d   Bodmer, W F ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d ST MARK S HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Colorectal cancer; E cadherin mutation; E cadherin expression; Loss of heterozygosity; Replication errors

Indexed keywords

UVOMORULIN;

ALLELE; ARTICLE; CANCER GENETICS; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE LOSS; GENE REPLICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0031008789     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.5.654     Document Type: Article

References (39)

1. Foulds L. The natural history of cancer. J Chronic Dis 1958; 8: 2-37.
2. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49: 3713-21.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
4. Peltomaki P. Microsatellite instability and hereditary nonpolyposis colon cancer. J Pathol 1995; 176: 329-30.
5. Radman M, Wagner R. Carcinogenesis. Missing mismatch repair. Nature 1993; 366: 722.
6. Parsons R, Myeroff L, Liu B, Willson J, Markowitz S, Kinzler K, Vogelstein B. Microsatellite instability and mutations of the transforming growth factor ß type II receptor gene in colorectal cancer. Cancer Res 1995; 55: 5548-50.
7. Redston M, Papadopoulos N, Caldas C, Kinzler K, Kern S. Common occurrence of APC and K-ras mutation in the spectrum of colitis-associated neoplasias. Gastroenterology 1995; 108: 383-92.
8. Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio LB, et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 1995; 55: 2035-8.
9. Bell SM, Kelly SA, Hoyle JA, Lewis FA, Taylor GR, Thompson H, et al. C-ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer 1991; 64: 174-8.
10. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990; 59: 237-52.
11. Hinck L, Nathke IS, Papkoff J, Nelson WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994; 125: 1327-40.
12. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci Suppl 1993; 17: 155-8.
13. Hulsken J, Behrens J, Birchmeier W. Tumor-suppressor gene products in cell contacts: the E-cadherin-APC-armadillo connection. Curr Opin Cell Biol 1994; 6: 711-6.
14. Hulsken J, Birchmeier W, Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 1994; 127: 2061-9.
15. Rubinfeld B, Souza B, Alben I, Muller O, Chamberlain SH, Masiarz FR, et al. Association of the APC gene product with beta-catenin. Science 1993; 262: 1731-4.
16. Cowin P. Unraveling the cytoplasmic interactions of the E-cadherin superfamily. Proc Natl Acad Sci USA 1994; 91: 10759-61.
17. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S, et al. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992; 52: 5770-4.
18. Takeichi M. The E-cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988; 102: 639-55.
19. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991; 51: 6328-37.
20. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, et al. Expression of the cellular adhesion molecular E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992; 52: 5104-9.
21. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 1994; 174: 243-8.
22. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993; 53: 1696-701.
23. Kinsella AR, Lepts GC, Hill CL, Jones M. Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis 1994; 12: 335-42.
24. Dorudi S, Hanby AM, Poulsom R, Northover J, Hart IR. Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 1995; 71: 614-6.
25. Nigam AK, Savage FJ, Boulos PB, Stamp GW, Liu D, Pignatelli M. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 1993; 68: 507-14.
26. Cowley GP, Smith ME. Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int J Cancer 1995; 60: 325-9.
27. van der Wurff AA, Arends JW, van der Linden EP, ten Kate J, Bosman FT. L-CAM expression in lymph node and liver metastases of colorectal carcinomas. J Pathol 1994; 172: 177-81.
28. Kinsella AR, Green B, Lepts GC, Hill CL, Bowie G, Taylor BA. The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br J Cancer 1993; 67: 904-9.
29. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-52.
30. Kanai Y, Oda T, Tsuda H, Ochiai A, Hirohashi S. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 1994; 85: 1035-9.
31. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, et al. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 1994; 91: 1858-62.
32. Risinger JI, Berchuck A, Kohler MF, Boyd J. Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 1994; 7: 98-102.
33. Bussemakers MJ, van Bokhoven A, Mees SG, Kemler R, Schalken JA. Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Rep 1993; 17: 123-8.
34. Ilyas M, Tomlinson IPM, Novelli M, Hanby A, Bodmer WF, Talbot IC. Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability. J Pathol 1996; 179: 370-5.
35. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 1995; 11: 475-84.
36. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55: 5195-9.
37. Birchmeier W, Behrens J, Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994; 1198: 11-26.
38. Shiozaki H, Iihira K, Oka H, Kadowaki T, Matsui S, Gofuku J, et al. Immunohistochemical detection of A-Catenin expression in human cancers. Am J Pathol 1994; 144: 667-74.
39. Takayama CT, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, et al. B Catenin expression in human cancers. Am J Pathol 1996; 148: 39-46.